Provectus Biopharmaceuticals, Inc. (PVCT) stock
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Provectus Biopharmaceuticals statistics
27 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- -0.00%
- 10.8%
- Shares Change (QoQ)
- 0.00%
- 0.49%
- Float
- 334M
- 49M
- Shares Held by Insiders
- 20.4%
- 11.6%
- Shares Held by Institutions
- 0.03%
- 56.4%
Returns on capitalIndustry
- Return on Assets (ROA)
- -1060.7%
- -40.6%
Financial positionIndustry
- Current Ratio
- 0.05
- 3.30
- Quick Ratio
- 0.03
- 2.39
- Interest Coverage
- -563.96
- -6.31
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -30.2%
- 2.25%
EfficiencyIndustry
- Profits Per Employee
- -$784.06K
- -$690.06K
- Employee Count
- 6
- 75
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $180.73K
- $17.80M
- Net Cash Per Share
- $0.00
- $0.80
- Equity (Book Value)
- -$6.66M
- $53.27M
- Book Value Per Share
- -$0.02
- $1.50
- Tangible Book Value
- -$6.66M
- $26.82M
- Working Capital
- -$6.73M
- $79.93M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- $8.01K
- $2.93M
Scores and fair valueIndustry
- Piotroski F-Score
- 1
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | PVCT | S&P 500 | Difference | PVCT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -11.1% | +0.6% | −11.7 pts | ||
| 3 months | -19.1% | +3.4% | −22.5 pts | ||
| Year to date | -12.5% | +13.3% | −25.8 pts | ||
| 1 year | -35.0% | +16.6% | −51.6 pts | ||
| 3 years | -24.8% | +86.4% | −111.1 pts | -9.1% | +23.1% |
| 5 years | -19.8% | +81.9% | −101.7 pts | -4.3% | +12.7% |
| 10 years | +4.0% | +318.9% | −314.8 pts | +0.4% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M PVCT shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 4.6 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 801,174 | 0.0% | 175,159 | 4.6 |
| Oct 15, 2026 | 801,174 | 0.0% | 138,697 | 5.8 |
| Sep 30, 2026 | 801,174 | 0.0% | 166,369 | 4.8 |
| Sep 15, 2026 | 801,174 | -0.1% | 175,553 | 4.6 |
| Aug 31, 2026 | 802,043 | 0.0% | 357,686 | 2.2 |
| Aug 14, 2026 | 802,043 | +0.0% | 209,040 | 3.8 |
| Jul 31, 2026 | 801,793 | -0.1% | 382,370 | 2.1 |
| Jul 15, 2026 | 802,797 | +10237.3% | 544,670 | 1.5 |
| Jun 30, 2026 | 7,766 | -99.0% | 285,814 | 1.0 |
| Jun 15, 2026 | 802,784 | +41110.7% | 182,658 | 4.4 |
| May 29, 2026 | 1,948 | -89.5% | 324,828 | 1.0 |
| May 15, 2026 | 18,505 | -97.7% | 318,127 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?